[go: up one dir, main page]

HRP20020835A2 - Formulation having mobilising activity - Google Patents

Formulation having mobilising activity

Info

Publication number
HRP20020835A2
HRP20020835A2 HR20020835A HRP20020835A HRP20020835A2 HR P20020835 A2 HRP20020835 A2 HR P20020835A2 HR 20020835 A HR20020835 A HR 20020835A HR P20020835 A HRP20020835 A HR P20020835A HR P20020835 A2 HRP20020835 A2 HR P20020835A2
Authority
HR
Croatia
Prior art keywords
formulation
mobilising
activity
mobilising activity
haematopoietic
Prior art date
Application number
HR20020835A
Other languages
English (en)
Inventor
Ferro Laura
Porta Roberto
Iacobelli Massimo
Massimo Gianni Alessandro
Carlo Stella Carmelo
Original Assignee
Gentium Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentium Spa filed Critical Gentium Spa
Publication of HRP20020835A2 publication Critical patent/HRP20020835A2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
HR20020835A 2000-04-18 2001-04-10 Formulation having mobilising activity HRP20020835A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00830293A EP1147777A1 (en) 2000-04-18 2000-04-18 Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors
PCT/EP2001/004105 WO2001078761A2 (en) 2000-04-18 2001-04-10 Mixture of defibrotide and g-csf ant its use for activating haematopoietic progenitors

Publications (1)

Publication Number Publication Date
HRP20020835A2 true HRP20020835A2 (en) 2005-10-31

Family

ID=8175292

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020835A HRP20020835A2 (en) 2000-04-18 2001-04-10 Formulation having mobilising activity

Country Status (31)

Country Link
US (1) US20040131588A1 (is)
EP (3) EP1147777A1 (is)
JP (1) JP5205668B2 (is)
KR (1) KR100849491B1 (is)
CN (1) CN1183962C (is)
AT (2) ATE310532T1 (is)
AU (2) AU5832201A (is)
BG (1) BG107203A (is)
CA (1) CA2406179C (is)
CY (1) CY1104971T1 (is)
CZ (1) CZ20023426A3 (is)
DE (2) DE60140015D1 (is)
DK (2) DK1276497T3 (is)
EE (1) EE200200596A (is)
ES (2) ES2252227T3 (is)
HR (1) HRP20020835A2 (is)
HU (1) HUP0300560A3 (is)
IL (1) IL152328A (is)
IS (1) IS2171B (is)
MX (1) MXPA02010346A (is)
NO (1) NO20024988L (is)
NZ (1) NZ522016A (is)
PL (1) PL358100A1 (is)
PT (1) PT1621207E (is)
RO (1) RO121006B1 (is)
RU (1) RU2248216C2 (is)
SI (1) SI21079B (is)
SK (1) SK14892002A3 (is)
UA (1) UA73566C2 (is)
WO (1) WO2001078761A2 (is)
ZA (1) ZA200208413B (is)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8771663B2 (en) 2000-04-18 2014-07-08 Gentium Spa Formulation having mobilising activity
PL1660115T3 (pl) * 2003-07-29 2011-11-30 Dompe Spa Farmaceutyczna kombinacja G-CSF i PLGF użyteczna wobec komórek macierzystych krwi
JP2007535479A (ja) 2003-08-13 2007-12-06 チルドレンズ ホスピタル メディカル センター ＧＴＰａｓｅを調節するためのキメラペプチド
US7417026B2 (en) 2003-08-13 2008-08-26 Children's Hospital Medical Center Mobilization of hematopoietic cells
EP2103689A1 (en) * 2008-03-19 2009-09-23 Gentium S.p.A. Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
RU2376985C1 (ru) * 2008-07-17 2009-12-27 Владислав Николаевич Ласкавый Средство для активации стволовых клеток
EP2637672B1 (en) 2010-11-12 2018-08-22 Gentium S.r.l. Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd).
CA2874960C (en) 2012-06-22 2021-05-18 Gentium S.P.A. Euglobulin-based method for determining the biological activity of defibrotide
EP3026122A1 (en) 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide
CN106567694A (zh) * 2016-11-14 2017-04-19 北京国泰通源技术有限公司 智能控水短节
RU2758487C2 (ru) * 2018-01-12 2021-10-28 Селлмиг Биолабс Инк. Способы получения цитокапсул и цитокапсулярных трубок
CN114730031B (zh) 2019-11-13 2024-04-12 富士胶片株式会社 装饰膜、成型物及电子器件

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899481A (en) 1970-11-03 1975-08-12 Crinos Industria Farmaco Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs
DE2154279A1 (de) * 1970-11-03 1972-05-25 Crinos Industria Farmaco Medikamente für das fibrinolytische System
IT1043823B (it) * 1970-11-03 1980-02-29 Prephar Procedimento per l estrazione di acidi nucleici da organi animali
IT1206341B (it) 1984-02-16 1989-04-14 Crinos Industria Farmaco Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
US4694134A (en) 1985-05-28 1987-09-15 Ajax Magnethermic Corporation Apparatus for overheating edges of skelp for the production of compression welded pipe
US5223609A (en) * 1986-04-17 1993-06-29 Crinos Industria Farmacobiologica S.P.A. Process for obtaining chemically defined and reproducible polydeoxyribonucleotides
IT1190313B (it) 1986-04-17 1988-02-16 Crinos Industria Farmaco Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
IT1223322B (it) * 1987-10-23 1990-09-19 Crinos Industria Farmaco Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso
JP2907447B2 (ja) * 1988-08-24 1999-06-21 中外製薬株式会社 抗血栓剤
IT1231509B (it) * 1989-09-07 1991-12-07 Crinos Industria Farmaco Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
US5977083A (en) * 1991-08-21 1999-11-02 Burcoglu; Arsinur Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
JP3021906B2 (ja) * 1992-01-28 2000-03-15 松下電器産業株式会社 電動調理機
RU2136667C1 (ru) * 1995-04-18 1999-09-10 Научно-исследовательский институт фармакологии РАМН Производные 2-меркаптобензимидазола, обладающие противоишемической, антиаритмической и противофибрилляторной активностью
JPH08127539A (ja) * 1994-10-31 1996-05-21 Ajinomoto Co Inc ヒトｉｌ−１１を含有する末梢血幹細胞増加剤
EP0801076A4 (en) * 1994-11-30 1999-12-15 Chugai Pharmaceutical Co Ltd THROMBOCYTOTIC FACTOR
CA2260014A1 (en) * 1996-07-10 1998-01-15 Meiji Milk Products Co., Ltd. Novel use of mk family as hematopoietic factor
WO1999026639A1 (en) * 1997-11-26 1999-06-03 Allegheny University Of The Health Sciences Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood
US6573372B2 (en) * 1999-01-07 2003-06-03 Heska Corporation Feline immunoglobulin E molecules and compositions there of

Also Published As

Publication number Publication date
IL152328A (en) 2009-12-24
ES2335776T3 (es) 2010-04-05
US20040131588A1 (en) 2004-07-08
SI21079A (sl) 2003-06-30
NO20024988D0 (no) 2002-10-16
JP5205668B2 (ja) 2013-06-05
DK1621207T3 (da) 2010-02-01
WO2001078761A2 (en) 2001-10-25
KR20030010603A (ko) 2003-02-05
RO121006B1 (ro) 2006-11-30
RU2248216C2 (ru) 2005-03-20
PL358100A1 (en) 2004-08-09
DK1276497T3 (da) 2006-03-27
SK14892002A3 (sk) 2003-06-03
IL152328A0 (en) 2003-05-29
PT1621207E (pt) 2009-12-28
NZ522016A (en) 2004-10-29
CN1434719A (zh) 2003-08-06
CA2406179A1 (en) 2001-10-25
ATE443524T1 (de) 2009-10-15
EP1276497A2 (en) 2003-01-22
ZA200208413B (en) 2003-10-17
DE60115222T2 (de) 2006-08-10
ATE310532T1 (de) 2005-12-15
EP1621207A2 (en) 2006-02-01
CZ20023426A3 (cs) 2003-05-14
DE60115222D1 (de) 2005-12-29
EP1276497B1 (en) 2005-11-23
EP1147777A1 (en) 2001-10-24
CA2406179C (en) 2012-03-27
EP1621207B1 (en) 2009-09-23
IS2171B (is) 2006-11-15
DE60140015D1 (de) 2009-11-05
AU2001258322B2 (en) 2006-03-16
CN1183962C (zh) 2005-01-12
EP1621207A3 (en) 2006-11-22
CY1104971T1 (el) 2010-03-03
MXPA02010346A (es) 2004-09-06
JP2004500437A (ja) 2004-01-08
HUP0300560A2 (hu) 2003-06-28
SI21079B (sl) 2006-08-31
UA73566C2 (en) 2005-08-15
KR100849491B1 (ko) 2008-07-31
RU2002130719A (ru) 2004-03-27
NO20024988L (no) 2002-12-02
WO2001078761A3 (en) 2002-01-24
IS6581A (is) 2002-10-14
HUP0300560A3 (en) 2005-07-28
BG107203A (bg) 2003-05-30
ES2252227T3 (es) 2006-05-16
AU5832201A (en) 2001-10-30
EE200200596A (et) 2004-04-15

Similar Documents

Publication Publication Date Title
HRP20020835A2 (en) Formulation having mobilising activity
AU2001269688A1 (en) Combination containing an antifolate and methylmalonic acid lowering agent
NO20061095L (no) Vertscelle som fremstiller chimerisk anti-CD2o-antistoff samt anvendelse derav ved fremstilling av medikamenter til behandling av lidelser som involverer B-celler
MY128208A (en) Body fluids absorbent article
DE69936545D1 (de) Saugfähiger gegenstand
PT1083899E (pt) Derivados de 1-desoxi-galactonojirimicina e respectiva utilização no tratamento de doenças de acumulação lisossomal, por intensificação da alfa-galactosidase a lisossomal
CO4700404A1 (es) Articulo absorbente con capacidad de adquisicion de liquido mejorada
GB9415167D0 (en) Improvements relating to cancer therapy
MXPA02003809A (es) Articulo absorbente desechable con estructura de contencion.
TW200505900A (en) Muscarinic agonists
IL158155A0 (en) Use of erythropoietin to ameliorate chemotherapy-induced toxicity in vivo
WO2001089536A3 (en) Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
CA2163118A1 (en) Aurintricaboxylic Acid Fractions and Analogues with Anti-Angiogenic Activity and Methods of Use
WO2003026574A3 (en) Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy
EP1023901A4 (en) MEDICINES FOR HEPATITIS C AND THE USE THEREOF
YU79802A (sh) Formulacija sa aktivnošću mobilizacije
EP1123100A4 (en) MEMORY IMPROVEMENT BY ADMINISTRATION OF DELTA-5-ANDROSTEN-3-BETA-OL-7,17-DION AND 3-BETA-ESTERS THEREOF
UA28031C2 (uk) Лікарська форма похідних 5- нітроімідазолу, фармацевтична композиція для лікування паразитарних та інфекційних захворювань шлунково-кишкового тракту, гастрозахищені мікрогранули похідних 5-нітроімідазолу, мікрогранули поkідних 5-нітроімідазолу з пролонгов
EP0340933A3 (en) Heparin-containing formulations
EP0458537A3 (en) Therapeutic compound for the treatment of bronchitis
NO307683B1 (no) Sitte-, ligge- eller støtteunderlag
Venger The structure of psychological syndrome
ES2086518T3 (es) Compuesto farmaceutico con accion cicatrizante.
Sterk The impact of family therapy on family interaction patterns: ten case reports
UA30444A (uk) Спосіб лікування ювенільної маткової кровотечі

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20080409

Year of fee payment: 8

ODBC Application rejected